Citibank, N.A. is a U.S.-chartered national bank and the primary banking subsidiary of Citigroup Inc. It provides retail and commercial banking services to individuals, businesses, and institutions worldwide, operating through a broad international branch network and affiliated entities. Core services include deposit accounts, lending, payments, cash management, trade finance, foreign exchange, and custody and securities services.
For companies in the chemical value chain, Citibank offers corporate and institutional banking solutions that support cross‑border operations and capital needs. These include working capital facilities, supply chain and receivables financing, letters of credit and guarantees for feedstocks and equipment, treasury and liquidity management, and risk management for interest rate and currency exposures. Through Citigroup affiliates, clients may also access capital markets and advisory capabilities. Citibank’s global footprint and transaction banking infrastructure are used by multinational chemical producers, distributors, and service providers to manage cash, finance trade, and facilitate international procurement and sales.
€9bn 5‑year revolver with 2‑year extension option refinancing prior €6bn and €3bn lines; provided by 28 banks, ~40% oversubscription, maintains financial flexibility and extends maturity
The financing supports Hail and Ghasha's gas production, with participation from over 20 financial institutions, enhancing project resilience and ADNOC's strategic growth.
The facility includes two tranches, supports ESG goals, and involves multiple banks. It refinances existing credit and offers a $400M Accordion Option.
The facility includes $2.11B one-year, $700M two-year tranches, and a $500M accordion. It was oversubscribed, adding four new banks, enhancing liquidity for energy commodities.
Roche's subsidiary accepted tendered shares of 89bio, planning a merger to make 89bio a wholly owned subsidiary, delisting it from Nasdaq.
